Kuan-Yu Lin1, Tzu-Cheng Su2, Chung-Min Yeh2,3, Wan-Ru Chao1,4,5, Wen-Wei Sung6,7,8. 1. School of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C. 2. Department of Pathology, Changhua Christian Hospital, Changhua, Taiwan, R.O.C. 3. Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan, R.O.C. 4. Department of Pathology, Chung Shan Medical University, Taichung, Taiwan, R.O.C. 5. Department of Pathology, Chung Shan Medical University Hospital, Taichung, Taiwan, R.O.C. 6. School of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.; flutewayne@gmail.com. 7. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C. 8. Department of Urology, Chung Shan Medical University Hospital, Taichung, Taiwan, R.O.C.
Abstract
BACKGROUND/AIM: Metastasis-associated protein 1 (MTA1) plays a role in ATP-dependent nucleosome disruption activity and histone deacetylase activity and may indicate DNA methylation activity. MTA1 may also be involved in the progression of oral squamous cell carcinoma (OSCC). PATIENTS AND METHODS: MTA1 immunoreactivity was analyzed using immunohistochemical (IHC) staining analysis in specimens from 281 OSCC patients. Kaplan-Meier analysis was used to determine the prognostic value of MTA1 for overall survival. RESULTS: High MTA1 expression was significantly associated with female gender and lymph node metastasis. Multivariate analyses showed the independent prognostic role of high MTA1 expression in patients with OSCC of poorer mean survival. CONCLUSION: MTA1 expression, detected by IHC staining, could be an independent prognostic marker for patients of OSCC.
BACKGROUND/AIM: Metastasis-associated protein 1 (MTA1) plays a role in ATP-dependent nucleosome disruption activity and histone deacetylase activity and may indicate DNA methylation activity. MTA1 may also be involved in the progression of oral squamous cell carcinoma (OSCC). PATIENTS AND METHODS: MTA1 immunoreactivity was analyzed using immunohistochemical (IHC) staining analysis in specimens from 281 OSCC patients. Kaplan-Meier analysis was used to determine the prognostic value of MTA1 for overall survival. RESULTS: High MTA1 expression was significantly associated with female gender and lymph node metastasis. Multivariate analyses showed the independent prognostic role of high MTA1 expression in patients with OSCC of poorer mean survival. CONCLUSION: MTA1 expression, detected by IHC staining, could be an independent prognostic marker for patients of OSCC.